Intensification regimen for advanced-stage resectable hypopharyngeal carcinoma

Archives of Otolaryngology - Head and Neck Surgery

Volumn 132, Issue 4, 2006, Pages 385-389

  Ozer, Enver ^a,b   Grecula, John C ^a   Agrawal, Amit ^a   Rhoades, Chris A ^a   Schuller, David E ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CISPLATIN; FLUCONAZOLE; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CONTROL; FEASIBILITY STUDY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; HYPOPHARYNX CARCINOMA; INFECTION; INTRAOPERATIVE RADIOTHERAPY; LARYNGECTOMY; LARYNX; MALE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PHASE 2 CLINICAL TRIAL; PRESERVATION; PROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TIME SERIES ANALYSIS;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEASIBILITY STUDIES; FEMALE; HUMANS; HYPOPHARYNGEAL NEOPLASMS; LARYNGECTOMY; MALE; MIDDLE AGED; OHIO; PACLITAXEL; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33645884412     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.132.4.385     Document Type: Article

References (20)

1. Hoffman HT, Karnell LH, Funk GF, Robinson RA, Menck HR. The National Cancer Data Base report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg. 1998;124:951-962.
2. Hoffman HT, Karnell LH, Shah JP, et al. Hypopharyngeal cancer patient care evaluation. Laryngoscope. 1997;107:1005-1017.
3. Johansen LV, Grau C, Overgaard J. Hypopharyngeal squamous cell carcinoma: treatment results in 138 consecutively admitted patients. Acta Oncol. 2000;39:529-536.
4. Fu KK. Combined-modality therapy for head and neck cancer. Oncology. 1997;11:1781-1796.
5. Al-Sarraf M, Pajak TF, Byhardt RW, Beitler JJ, Salter MM, Cooper JS. Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24. Int J Radiat Oncol Biol Phys. 1997;37:777-782.
6. Hanna E, Alexiou M, Morgan J, et al. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations. Arch Otolaryngol Head Neck Surg. 2004;130:861-867.
7. Schuller DE, Grecula JC, Gahbauer RA, et al. Intensified regimen for advanced head and neck squamous cell carcinomas. Arch Otolaryngol Head Neck Surg. 1997;123:139-144.
8. Grecula JC, Schuller DE, Rhoades CA, et al. Intensification regimen 2 for advanced head and neck squamous cell carcinomas. Arch Otolaryngol Head Neck Surg. 1999;125:1313-1318.
9. Grecula JC, Smith RE, Rhoades CA, et al. Induction paclitaxel in previously untreated, resectable, advanced squamous cell carcinomas of the head and neck. Cancer. 2000;89:2587-2596.
10. Schuller DE, Laramore G, Al-Sarraf M, Jacobs J, Pajak TF. Combined therapy for resectable head and neck cancer: a phase 3 intergroup study. Arch Otolaryngol Head Neck Surg. 1989;115:364-368.
11. Schuller DE, Grecula JC, Agrawal A, et al. Multimodal intensification therapy for previously untreated advanced resectable squamous cell carcinoma of the oral cavity, oropharynx, or hypopharynx. Cancer. 2002;94:3169-3178.
12. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data: MACH-NC Collaborative Group. Lancet. 2000;355:949-955.
13. Zelefsky MJ, Kraus DH, Pfister DG, et al. Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer. Head Neck. 1996;18:405-411.
14. Pinheiro AD, Foote RL, McCaffrey TV, et al. Intraoperative radiotherapy for head and neck and skull base cancer. Head Neck. 2003;25:217-226.
15. Freeman SB, Hamaker RC, Rate WR, et al. Management of advanced cervical metastasis using intraoperative radiotherapy. Laryngoscope. 1995;105:575-578.
16. Eckardt A, Rades D, Rudat V, et al. Prospective phase II study of neoadjuvant radiochemotherapy in advanced operable carcinoma of the mouth cavity: 3-year outcome [in German]. Mund Kiefer Gesichtschir. 2002;6:117-121.
17. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004;350:1937-1944.
18. Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350:1945-1952.
19. Beauvillain C, Mahe M, Bourdin S, et al. Final results of a randomized trial comparing chemotherapy plus radiotherapy with chemotherapy plus surgery plus radiotherapy in locally advanced resectable hypopharyngeal carcinomas. Laryngoscope. 1997;107:648-653.
20. Lefebvre JL, Chevalier D, Luboinski B,, et al. Larynx reservation in pyriform sinus cancer: preliminary results of a European Organisation for Research and Treatment of Cancer phase III trial: EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst. 1996;3:890-899.